Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $343.40 | Total: $1,717.00 |
| 1 | 10 | $290.88 | Total: $2,908.80 |
| 1 | 25 | $246.44 | Total: $6,161.00 |
| 1 | 50 | $210.08 | Total: $10,504.00 |
| 1 | 100 | $181.80 | Total: $18,180.01 |
Overview
M617 acetate is a selective agonist of galanin receptor 1 (GAL1). M617 acetate acts through central GAL1, promotes GLUT4 expression, and enhances GLUT4 content in the cardiac muscle of type 2 diabetic rats. The Ki values are 0.23 and 5.71 nM for GAL1 and GAL2, respectively.
Chemical Properties
| Molecular Formula | C112H161N29O28 |
| Molecular Weight | 2361.65 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | CC(C)C[C@@H](C(NCC(N(CCC1)[C@@H]1C(N[C@@H](CCC(N)=O)C(N(CCC1)[C@@H]1C(N(CCC1)[C@@H]1C(NCC(N[C@@H](Cc1ccccc1)C(N[C@@H](CO)C(N(CCC1)[C@@H]1C(N[C@@H](Cc1ccccc1)C(N[C@@H](CCCNC(N)=N)C(N)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)NC([C@H](CC(C)C)NC([C@H](Cc(cc1)ccc1O)NC(CNC([C@H](C)NC([C@H](CO)NC([C@H](CC(N)=O)NC([C@H](CC(C)C)NC([C@H]([C@@H](C)O)NC([C@H](Cc1c[nH]c2c1cccc2)NC(CN)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O |
Storage and Handling
0C Short Term, -20C Long Term
References
Fang P, et al. Central injection of GalR1 agonist M617 facilitates GLUT4 expression in cardiac muscle of type 2 diabetic rats. Exp Gerontol. 2015;65 85-89.